[Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., Sayegh, M. H. (2008). Immunomodulation by mesenchymal stem cells. Diabetes,57, 1759–1767.10.2337/db08-0180245363118586907]Search in Google Scholar
[Anjos-Afonso, F., Siapati, E. K., Bonnet, D. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci.,117, 5655–5664.10.1242/jcs.0148815494370]Search in Google Scholar
[Anonymous (2007). No. 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) no 726/2004. J. Eur. Union, 324, 121–137.]Search in Google Scholar
[Anonymous (2014). Report from the commission to the European Parliament and the Council in accordance with article 25 of regulation (EC) no 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) no 726/2004. Available from: https://publications.europa.eu/en/publication-detail/-/publication/2dc18b82-b6c8-11e3-86f9-01aa75ed71a1 (accessed 30.01.2018).]Search in Google Scholar
[Anonymous (2015). General Secretariat of the Council to Delegations; Document number 15054/15: Personalised medicine for patients: Council conclusions. 07.12.2015. Available from: http://data.consilium.europa.eu/doc/document/ST-15054-2015-INIT/en/pdf (accessed 30.01.2018).]Search in Google Scholar
[Basciano, L., Nemos, C., Foliguet, B., de Isla, N., de Carvalho, M., Tran, N., Dalloul, A. (2011). Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol.,12, 12.10.1186/1471-2121-12-12307390021450070]Search in Google Scholar
[Bentzon, J. F., Stenderup, K., Hansen, F. D., Schroder, H. D., Abdallah, B. M., Jensen, T. G., Kassem, M. (2005). Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem. Biophys. Res. Comm.,330, 633–640.10.1016/j.bbrc.2005.03.07215809044]Search in Google Scholar
[Blythe, L. L., Craig, A. M., Christensen, J. M., Appell, L. H., Slizeski, M. L. (1986). Pharmacokinetic disposition of dimethyl sulfoxide administered intravenously to horses. Amer. J. Vet. Res.,47, 1739–1743.]Search in Google Scholar
[Bogdanova, A., Berzins, U., Nikulshin, S., Skrastina, D., Ezerta, A., Legzdina, D., Kozlovska, T. (2014). Characterization of human adipose-derived stem cells cultured in autologous serum after subsequent passaging and long term cryopreservation. J. Stem Cells,9, 135–148.]Search in Google Scholar
[Carrade, D. D., Borjesson, D. L. (2013). Immunomodulation by mesenchymal stem cells in veterinary species. Compar. Med.,63, 207–217.]Search in Google Scholar
[Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., Uccelli, A. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood, 107, 367–372.10.1182/blood-2005-07-265716141348]Search in Google Scholar
[Cyranoski, D. (2010). Korean deaths spark inquiry. Nature, 468, 485.10.1038/468485a21107396]Search in Google Scholar
[de Bakker, E., Van Ryssen, B., De Schauwer, C., Meyer, E. (2013). Canine mesenchymal stem cells: State of the art, perspectives as therapy for dogs and as a model for man. Vet. Quart., 33, 225–233.10.1080/01652176.2013.87396324404887]Search in Google Scholar
[De Jesus, M. M., Santiago, J. S., Trinidad, C. V., See, M. E., Semon, K. R., Fernandez, M. O., Jr., Chung, F. S. (2016). Autologous adipose-derived mesenchymal stromal cells for the treatment of Psoriasis vulgaris and psoriatic arthritis: A case report. Cell Transplant., 25, 2063–2069.10.3727/096368916X69199827301844]Search in Google Scholar
[Desiderio, V., De Francesco, F., Schiraldi, C., De Rosa, A., La Gatta, A., Paino, F., d’Aquino, R., Ferraro, G. A., Tirino, V., Papaccio, G. (2013). Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-Lys scaffold fabricate a skeletal muscle tissue. J. Cell. Physiol., 228, 1762–1773.10.1002/jcp.2433623359523]Search in Google Scholar
[Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., Gianni, A. M. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838–3843.10.1182/blood.V99.10.383811986244]Search in Google Scholar
[Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315–-317.10.1080/14653240600855905]Search in Google Scholar
[Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., Hoogduijn, M. J. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers Immunol., 3, 297.10.3389/fimmu.2012.00297345830523056000]Search in Google Scholar
[Eggenhofer, E., Luk, F., Dahlke, M. H., Hoogduijn, M. J. (2014). The life and fate of mesenchymal stem cells. Frontiers Immunol., 5, 148.10.3389/fimmu.2014.00148403290124904568]Search in Google Scholar
[Fang, B., Li, N., Song, Y., Li, J., Zhao, R. C., Ma, Y. (2009). Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatric Transplant., 13, 499–502.10.1111/j.1399-3046.2008.01002.x18673358]Search in Google Scholar
[Fang, B., Song, Y., Liao, L., Zhang, Y., Zhao, R. C. (2007). Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant. Proc., 39, 3358–3362.10.1016/j.transproceed.2007.08.10318089385]Search in Google Scholar
[Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., Cox, C. S., Jr. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Devel., 18, 683–692.10.1089/scd.2008.0253319029219099374]Search in Google Scholar
[Furlani, D., Ugurlucan, M., Ong, L., Bieback, K., Pittermann, E., Westien, I., Wang, W., Yerebakan, C., Li, W., Gaebel, R., Li, R. K., Vollmar, B., Steinhoff, G., Ma, N. (2009). Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc. Res., 77, 370–376.10.1016/j.mvr.2009.02.00119249320]Search in Google Scholar
[Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., Noel, D. (2010). Immunosuppression by mesenchymal stem cells: Mechanisms and clinical applications. Stem Cell Res. Ther., 1, 2.10.1186/scrt2287369820504283]Search in Google Scholar
[Hall, M. N., Rosenkrantz, W. S., Hong, J. H., Griffin, C. E., Mendelsohn, C. M. (2010). Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: A pilot study. Vet. Ther. Res. Appl. Vet. Med., 11, E1–14.]Search in Google Scholar
[Han, S. M., Kim, H. T., Kim, K. W., Jeon, K. O., Seo, K. W., Choi, E. W., Youn, H. Y. (2015). CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus. BMC Vet. Res., 11, 49.10.1186/s12917-015-0371-3441722225889154]Search in Google Scholar
[Hoffman, A. M., Dow, S. W. (2016). Concise review: Stem cell trials using companion animal disease models. Stem Cells (Dayton, Ohio), 34, 1709–1729.10.1002/stem.237727066769]Search in Google Scholar
[Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S. G., Kocsis, J. D. (2011). Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain, 134, 1790–1807.10.1093/brain/awr063310223721493695]Search in Google Scholar
[Hu, X., Yu, S. P., Fraser, J. L., Lu, Z., Ogle, M. E., Wang, J. A., Wei, L. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thor. Cardiovasc. Surg., 135, 799–808.10.1016/j.jtcvs.2007.07.07118374759]Search in Google Scholar
[Hung, S. C., Pochampally, R. R., Hsu, S. C., Sanchez, C., Chen, S. C., Spees, J., Prockop, D. J. (2007). Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PloS One, 2, e416.10.1371/journal.pone.0000416185507717476338]Search in Google Scholar
[Ivanovic, Z. (2009). Hypoxia or in situ normoxia: The stem cell paradigm. J. Cell. Physiol., 219, 271–275.10.1002/jcp.2169019160417]Search in Google Scholar
[Jung, J. W., Kwon, M., Choi, J. C., Shin, J. W., Park, I. W., Choi, B. W., Kim, J. Y. (2013). Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy. Yonsei Med. J.,54, 1293–1296.10.3349/ymj.2013.54.5.1293374320423918585]Search in Google Scholar
[Kang, J. W., Kang, K. S., Koo, H. C., Park, J. R., Choi, E. W., Park Y. H. (2008). Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells. Stem Cells Devel., 17, 681–694.10.1089/scd.2007.015318717642]Search in Google Scholar
[Kang, M. H., Park, H. M. (2014). Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation. Acta Vet. Scand., 56, 16.10.1186/1751-0147-56-16399452224655411]Search in Google Scholar
[Karagiannis, K., Proklou, A., Tsitoura, E., Lasithiotaki, I. (2017). Impaired mRNA expression of the migration related chemokine receptor CXCR4 in mesenchymal stem cells of COPD patients. Int. J. Inflam., 2017, 6089425.10.1155/2017/6089425553994228804668]Search in Google Scholar
[Kim, M., Kim, D. I., Kim, E. K., Kim, C. W. (2017). CXCR4 overexpression in human adipose tissue-derived stem cells improves homing and engraftment in an animal limb ischemia model. Cell Transplant.,26, 191–204.10.3727/096368916X692708565775827501830]Search in Google Scholar
[Kisiel, A. H., McDuffee, L. A., Masaoud, E., Bailey, T. R., Esparza Gonzalez, B. P., Nino-Fong, R. (2012). Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Amer. J. Vet. Res., 73, 1305–1317.10.2460/ajvr.73.8.130522849692]Search in Google Scholar
[Kraitchman, D. L., Tatsumi, M., Gilson, W. D., Ishimori, T., Kedziorek, D., Walczak, P., Segars, W. P., Chen, H. H., Fritzges, D., Izbudak, I., Young, R. G., Marcelino, M., Pittenger, M. F., Solaiyappan, M., Boston, R. C., Tsui, B. M., Wahl, R. L., Bulte, J. W. (2005). Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation, 112, 1451–1461.10.1161/CIRCULATIONAHA.105.537480145673116129797]Search in Google Scholar
[Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., Ringden, O. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol., 57, 11–20.10.1046/j.1365-3083.2003.01176.x12542793]Search in Google Scholar
[Lee, E. Y., Xia, Y., Kim, W. S., Kim, M. H., Kim, T. H., Kim, K. J., Park, B. S., Sung, J. H. (2009). Hypoxia-enhanced wound-healing function of adipose-derived stem cells: Increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen.,17, 540–547.10.1111/j.1524-475X.2009.00499.x19614919]Search in Google Scholar
[Legzdina, D., Romanauska, A., Nikulshin, S., Kozlovska, T., Berzins, U. (2016). Characterization of senescence of culture-expanded human adipose-derived mesenchymal stem cells. Int. J. Stem Cells, 9, 124–136.10.15283/ijsc.2016.9.1.124496111227426094]Search in Google Scholar
[Leroux, L., Descamps, B., Tojais, N. F., Seguy, B., Oses, P., Moreau, C., Daret, D., Ivanovic, Z., Boiron, J. M., Lamaziere, J.M., Dufourcq, P., Couffinhal, T., Duplaa, C. (2010). Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a Wnt4-dependent pathway. Mol. Ther.,18, 1545–1552.10.1038/mt.2010.108292705920551912]Search in Google Scholar
[Li, Q., Zhang, A., Tao, C., Li, X., Jin, P. (2013). The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro. Biochem. Biophys. Res. Comm., 441, 675–680.10.1016/j.bbrc.2013.10.07124184476]Search in Google Scholar
[Lim, J. Y., Ra, J. C., Shin, I. S., Jang, Y. H., An, H. Y., Choi, J. S., Kim, W. C., Kim, Y. M. (2013). Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PloS One, 8, e71167.10.1371/journal.pone.0071167373979523951100]Search in Google Scholar
[Liu, H., Liu, S., Li, Y., Wang, X., Xue, W., Ge, G., Luo, X. (2012). The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-pre-conditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PloS One, 7, e34608.10.1371/journal.pone.0034608]Search in Google Scholar
[Lo Sicco, C., Reverberi, D., Balbi, C., Ulivi, V., Principi, E., Pascucci, L., Becherini, P., Bosco, M. C., Varesio, L., Franzin, C., Pozzobon, M., Cancedda, R., Tasso, R. (2017). Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: Endorsement of macrophage polarization. Stem Cells Transl. Med., 6, 1018–1028.10.1002/sctm.16-0363544278328186708]Search in Google Scholar
[Lysaght, T., Lipworth, W., Hendl, T., Kerridge, I., Lee, T.L., Munsie, M., Waldby, C., Stewart, C. (2017). The deadly business of an unregulated global stem cell industry. J. Med. Ethics, 43 (11).10.1136/medethics-2016-10404628356490]Search in Google Scholar
[Martinello, T., Bronzini, I., Maccatrozzo, L., Mollo, A., Sampaolesi, M., Mascarello, F., Decaminada, M., Patruno, M. (2011). Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res. Vet. Sci.,91, 18–24.10.1016/j.rvsc.2010.07.02420732703]Search in Google Scholar
[McIntosh, K. R., Frazier, T., Rowan, B. G., Gimble, J. M. (2013). Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics. Expert Rev. Clin. Immunol., 9, 175–184.10.1586/eci.12.9623390948]Search in Google Scholar
[Moll, G., Le Blanc, K. (2015). Engineering more efficient multipotent mesenchymal stromal (stem) cells for systemic delivery as cellular therapy. ISBT Science Series, 10, 357–365.10.1111/voxs.12133]Search in Google Scholar
[Muzes, G., Sipos, F. (2016). Heterogeneity of stem cells: A brief overview. Meth. Mol. biol. (Clifton, N.J.), 1516, 1–12.10.1007/7651_2016_34527044045]Search in Google Scholar
[Neupane, M., Chang, C.C., Kiupel, M., Yuzbasiyan-Gurkan, V. (2008). Isolation and characterization of canine adipose-derived mesenchymal stem cells. Tissue Eng. Part A, 14, 1007–1015.10.1089/ten.tea.2007.0207]Search in Google Scholar
[O’Kell, A. L., Wasserfall, C., Catchpole, B., Davison, L. J., Hess, R. S., Kushner, J. A., Atkinson, M. A. (2017). Comparative pathogenesis of autoimmune diabetes in humans, NOD mice, and canines: Has a valuable animal model of Type 1 Diabetes been overlooked? Diabetes, 66, 1443–1452.10.2337/db16-1551544002228533295]Search in Google Scholar
[Prologo, J. D., Hawkins, M., Gilliland, C., Chinnadurai, R., Harkey, P., Chadid, T., Lee, Z., Brewster, L. (2016). Interventional stem cell therapy. Clin. Radiol., 71, 307–311.10.1016/j.crad.2016.01.00526874660]Search in Google Scholar
[Ra, J. C., Kang, S. K., Shin, I. S., Park, H. G., Joo, S. A., Kim, J. G., Kang, B.-C., Lee, Y. S., Nakama, K., Piao, M. (2011a). Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J. Translat. Med., 9, 181.10.1186/1479-5876-9-181322261722017805]Search in Google Scholar
[Ra, J. C., Shin, I. S., Kim, S. H., Kang, S. K., Kang, B. C., Lee, H. Y., Kim, Y. J., Jo, J. Y., Yoon, E. J., Choi, H. J. (2011b). Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Devel., 20, 1297–1308.10.1089/scd.2010.046621303266]Search in Google Scholar
[Reich, C. M., Raabe, O., Wenisch, S., Bridger, P. S., Kramer, M., Arnhold, S. (2012). Isolation, culture and chondrogenic differentiation of canine adipose tissue-and bone marrow-derived mesenchymal stem cells—a comparative study. Vet. Res. Comm., 36, 139–148.10.1007/s11259-012-9523-022392598]Search in Google Scholar
[Rosova, I., Dao, M., Capoccia, B., Link, D., Nolta, J. A. (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells (Dayton, Ohio), 26, 2173–2182.10.1634/stemcells.2007-1104301747718511601]Search in Google Scholar
[Russell, K. A., Chow, N. H. C., Dukoff, D., Gibson, T. W. G., LaMarre, J., Betts, D. H., Koch, T. G. (2016). Characterization and immunomodulatory effects of canine adipose tissue- and bone marrow-derived mesenchymal stromal cells. PLoS One, 11, e0167442.10.1371/journal.pone.0167442513197727907211]Search in Google Scholar
[Sato, J., Doi, T., Wako, Y., Hamamura, M., Kanno, T., Tsuchitani, M., Narama, I. (2012). Histopathology of incidental findings in beagles used in toxicity studies. J. Toxicol. Pathol., 25, 103–134.10.1293/tox.25.103332016022481862]Search in Google Scholar
[Shapiro, H. M., Shapiro, H. M. (2003). Practical Flow Cytometry. 4th edn. Wiley-Liss. 736 pp.10.1002/0471722731]Search in Google Scholar
[Sparrow, R. L., Tippett, E. (2005). Discrimination of live and early apoptotic mononuclear cells by the fluorescent SYTO 16 vital dye. J. Immunol. Meth., 305, 173–187.10.1016/j.jim.2005.07.01716165150]Search in Google Scholar
[Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S. C., Smith, J., Prockop, D. J. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther.,9, 747–756.10.1016/j.ymthe.2004.02.01215120336]Search in Google Scholar
[Stepien, A., Dabrowska, N. L., Maciagowska, M., Macoch, R. P. (2016). Clinical application of autologous adipose stem cells in patients with multiple sclerosis: Preliminary results, Mediators Inflamm., 2016, 5302120.10.1155/2016/5302120505957627761060]Search in Google Scholar
[Sullivan, M. O., Gordon-Evans, W. J., Fredericks, L. P., Kiefer, K., Conzemius, M. G., Griffon, D. J. (2016). Comparison of mesenchymal stem cell surface markers from bone marrow aspirates and adipose stromal vascular fraction sites. Frontiers Vet. Sci., 2, 82.10.3389/fvets.2015.00082471384026835460]Search in Google Scholar
[Takemitsu, H., Zhao, D., Yamamoto, I., Harada, Y., Michishita, M., Arai, T. (2012). Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells. BMC Vet. Res., 8, 150.10.1186/1746-6148-8-150344296122937862]Search in Google Scholar
[Tatsumi, K., Ohashi, K., Matsubara, Y., Kohori, A., Ohno, T., Kakidachi, H., Horii, A., Kanegae, K., Utoh, R., Iwata, T., Okano, T. (2013). Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem. Biophys. Res. Comm., 431, 203–209.10.1016/j.bbrc.2012.12.13423313481]Search in Google Scholar
[Tsai, C. C., Chen, Y. J., Yew, T. L., Chen, L. L., Wang, J. Y., Chiu, C. H., Hung, S. C. (2011). Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood, 117, 459–469.10.1182/blood-2010-05-28750820952688]Search in Google Scholar
[Tsuji, W., Rubin, J. P., Marra, K. G. (2014). Adipose-derived stem cells: Implications in tissue regeneration. World J. Stem Cells, 6, 312–321.10.4252/wjsc.v6.i3.312413127325126381]Search in Google Scholar
[Tyndall, A., Uccelli, A. (2009). Multipotent mesenchymal stromal cells for autoimmune diseases: Teaching new dogs old tricks. Bone Marrow Transplantation, 43, 821–828.10.1038/bmt.2009.6319308035]Search in Google Scholar
[Veriter, S., Andre, W., Aouassar, N., Poirel, H. A., Lafosse, A., Docquier, P. L., Dufrane, D. (2015). Human adipose-derived mesenchymal stem cells in Cell therapy: Safety and feasibility in different “Hospital Exemption” clinical applications. PloS One, 10, e0139566.10.1371/journal.pone.0139566461562026485394]Search in Google Scholar
[Vieira, N. M., Brandalise, V., Zucconi, E., Secco, M., Strauss, B. E., Zatz, M. (2010). Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant., 19, 279–289.10.3727/096368909X48176419995482]Search in Google Scholar
[Vives, J., Carmona, G. (2015). Guide to Cell Therapy GxP: Quality Standards in the Development of Cell-Based Medicines in Non-pharmaceutical Environments. Academic Press. 266 pp.]Search in Google Scholar
[Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., Hedrick, M. H. (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell, 13, 4279–4295.10.1091/mbc.e02-02-010513863312475952]Search in Google Scholar
[Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., Hedrick, M. H. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng., 7, 211–228.10.1089/10763270130006285911304456]Search in Google Scholar